Literature DB >> 25482333

The complexity and difficulty of diagnosing lung cancer: findings from a national primary-care study in Wales.

Richard D Neal1, Iain J Robbé2, Malcolm Lewis3, Ian Williamson4, Jane Hanson5.   

Abstract

AIM: This paper aims to provide a detailed analysis of the diagnostic process of lung cancer from a primary-care perspective.
BACKGROUND: Diagnosing lung cancer at a stage where curative treatment is possible remains a challenge. Beginning to understand the complexity and difficulty in the diagnostic journey should enable the development of interventions in order to facilitate timelier diagnosis.
METHODS: A national study of significant events was conducted whereby general practitioners (GPs) in Wales were asked to report data relating to the diagnostic process of recent lung cancer diagnoses using a standard template. Both qualitative and quantitative data were analysed. Findings Case reports were received from 96 general practices on 118 patients. A total of 96 patients (81.4%) presented with respiratory symptoms. A total of 79 patients (66.9%) had a GP-initiated X-ray before diagnosis. A total of 23 patients (19.5%) had a chest X-ray that did not initially show suspicion of lung cancer. A total of 25 patients (21.2%) were diagnosed after a GP-initiated acute admission. Analysis of free-text qualitative data showed that, for many patients, their GP behaved in an exemplary manner. However, for some patients, the GP could have made more of the opportunities presented for timelier diagnosis. There were a number of atypical and complex presentations, where the opportunities for more timely diagnosis were more limited. A variety of causes of diagnostic delays in secondary care were reported. These findings will inform health policy, and will inform the design of interventions to try to facilitate more timely diagnosis for symptomatic patients. We encourage greater compliance with diagnostic guidelines and greater vigilance for patients presenting with atypical symptoms, as well as for patients whose initial chest X-rays are normal.

Entities:  

Keywords:  diagnosis; lung cancer; primary care; significant event

Mesh:

Year:  2014        PMID: 25482333     DOI: 10.1017/S1463423614000516

Source DB:  PubMed          Journal:  Prim Health Care Res Dev        ISSN: 1463-4236            Impact factor:   1.458


  14 in total

1.  ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.

Authors:  Christopher G England; Dawei Jiang; Reinier Hernandez; Haiyan Sun; Hector F Valdovinos; Emily B Ehlerding; Jonathan W Engle; Yunan Yang; Peng Huang; Weibo Cai
Journal:  Mol Pharm       Date:  2017-09-06       Impact factor: 4.939

Review 2.  Defining timeliness in care for patients with lung cancer: a scoping review.

Authors:  Adnan Ansar; Virginia Lewis; Christine Faye McDonald; Chaojie Liu; Muhammad Aziz Rahman
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

3.  Urgent cancer referrals: how well are they working and can they be improved?

Authors:  Richard D Neal; Lesley Smith
Journal:  Br J Gen Pract       Date:  2021-08-26       Impact factor: 6.302

4.  The diagnostic performance of chest radiographs for lung malignancy in symptomatic primary-care populations: A systematic review and meta-analysis.

Authors:  Louis Dwyer-Hemmings; Cassandra Fairhead
Journal:  BJR Open       Date:  2021-07-29

5.  Unintended consequences of an 'all-clear' diagnosis for potential cancer symptoms: a nested qualitative interview study with primary care patients.

Authors:  Cristina Renzi; Katriina L Whitaker; Kelly Winstanley; Susanne Cromme; Jane Wardle
Journal:  Br J Gen Pract       Date:  2016-02-07       Impact factor: 5.386

6.  Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial.

Authors:  Richard D Neal; Allan Barham; Emily Bongard; Rhiannon Tudor Edwards; Jim Fitzgibbon; Gareth Griffiths; Willie Hamilton; Kerenza Hood; Annmarie Nelson; David Parker; Cath Porter; Hayley Prout; Kirsty Roberts; Trevor Rogers; Emma Thomas-Jones; Angela Tod; Seow Tien Yeo; Chris N Hurt
Journal:  Br J Cancer       Date:  2017-01-10       Impact factor: 7.640

7.  Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).

Authors:  Usha Menon; Peter Vedsted; David Weller; Alina Zalounina Falborg; Henry Jensen; Samantha Harrison; Irene Reguilon; Andriana Barisic; Rebecca J Bergin; David H Brewster; John Butler; Odd Terje Brustugun; Oliver Bucher; Victoria Cairnduff; Anna Gavin; Eva Grunfeld; Elizabeth Harland; Jatinderpal Kalsi; Anne Kari Knudsen; Mats Lambe; Rebecca-Jane Law; Yulan Lin; Martin Malmberg; Donna Turner; Richard D Neal; Victoria White
Journal:  BMJ Open       Date:  2019-11-27       Impact factor: 2.692

8.  Antibacterial and Anticancer Activity and Untargeted Secondary Metabolite Profiling of Crude Bacterial Endophyte Extracts from Crinum macowanii Baker Leaves.

Authors:  Tendani E Sebola; Nkemdinma C Uche-Okereafor; Lukhanyo Mekuto; Maya Mellisa Makatini; Ezekiel Green; Vuyo Mavumengwana
Journal:  Int J Microbiol       Date:  2020-12-10

9.  The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma.

Authors:  Zhi-Hong Jian; Jing-Yang Huang; Frank Cheau-Feng Lin; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Yu-Chiu Liang; Ming-Fang Wu; Yung-Po Liaw
Journal:  BMC Pulm Med       Date:  2015-12-03       Impact factor: 3.317

10.  Attitudes towards lung cancer screening in a population sample.

Authors:  Stephanie E Smits; Grace M McCutchan; Jane A Hanson; Kate E Brain
Journal:  Health Expect       Date:  2018-08-07       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.